Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-labelled Nano Molecules
- 4 October 2024
- journal article
- research article
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 212,p. e67048
Abstract
Small animal Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) imaging techniques are crucial in preclinical cancer research, necessitating meticulous attention to radiotracer synthesis, quality assurance, and in vivo injection protocols. This study presents a comprehensive workflow tailored to enhance the robustness and reproducibility of small animal PET experiments. The synthesis process in the radiochemistry laboratory using 68Ga is detailed, highlighting stringent quality control and assurance protocols for each radiotracer production. Parameters such as concentration, molar activity, pH, and purity are rigorously monitored, aligning with standards applicable to human studies. This methodology introduces streamlined syringe preparation and a custom-designed 30G cannula for precise intravenous injections into mice. Monitoring of animal health during scanning, including temperature and heart rate, ensures their well-being throughout the procedure. Dosages for PET and SPECT scans are predetermined to balance data acquisition with minimizing radiation exposure to animals and researchers. Similarly, CT scans employ pre-programmed settings to limit radiation exposure, especially pertinent in long-term studies assessing treatment effects. By optimizing these steps, the workflow aims to standardize procedures, reduce variability, and enhance the quality of small animal PET/SPECT/CT imaging. This resource provides valuable insights for researchers seeking to improve the accuracy and reliability of preclinical investigations in molecular imaging, ultimately advancing the field.Keywords
This publication has 13 references indexed in Scilit:
- Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory frameworkEJNMMI Radiopharmacy and Chemistry, 2024
- Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticalsEJNMMI Radiopharmacy and Chemistry, 2022
- Use of Radionuclide-Based Imaging Methods in Breast CancerSeminars in Nuclear Medicine, 2022
- HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0PLOS Biology, 2020
- PREPARE: guidelines for planning animal research and testingLaboratory Animals, 2017
- Statistical controversies in clinical research: publication bias evaluations are not routinely conducted in clinical oncology systematic reviewsAnnals of Oncology, 2016
- A critical evaluation of Amicon Ultra centrifugal filters for separating proteins, drugs and nanoparticles in biosamplesJournal of Pharmaceutical and Biomedical Analysis, 2016
- Tumour heterogeneity in the clinicNature, 2013
- Mycoplasma testing of cell substrates and biologics: Review of alternative non-microbiological techniquesMolecular and Cellular Probes, 2011